Another study showed that, in the case of gene deletion of IRE1α, colon cancer cells are sensitive to mitogen-activated protein kinase (MEK) inhibitor KRAS mutants (Sustic et al., 2018). The gene discussed is ERN1; the disease is malignant colon neoplasm.